We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Acid-Seeking "Warheads” Offer Safer, More Effective Cancer-Fighting Arsenal

By Biotechdaily staff writers
Posted on 11 Mar 2008
Researchers have recently reported on development of an anti-cancer "warhead” that targets the acidic signature of tumor cells in much the same way that heat-seeking missiles seek and destroy military targets that emit heat. These acid-seeking compounds are not toxic to healthy cells, and represent a new class of potentially safer, more effective anti-cancer drugs, according to the researchers.

The investigators' study is scheduled for the March 6, 2008, issue of The Journal of Physical Chemistry B. Scientists have long tried to develop anti-cancer drugs based on enediynes, a powerful class of natural, tumor-fighting agents derived from soil bacteria. However, as these substances kill both cancerous and healthy cells, their effectiveness as anti-cancer drugs is limited.

In the new study, Dr. Elfi Kraka and colleagues from the University of the Pacific (Stockton, CA, USA) described making unusual substances that become highly active only in the presence of low pH levels, or acidic environments. Because cancer cells have highly acidic environments in comparison to normal cells, compounds containing these substances--called dynemicin-amidines (DADs)--target and destroy tumor cells without affecting healthy cells, according to the researchers. The substances represent "the design of the first nontoxic enediyne antitumor drugs based on the DAD principle,” the report stated.


Related Links:
University of the Pacific

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Gold Member
Hematology Analyzer
Medonic M32B

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
11 Mar 2008  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
11 Mar 2008  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
11 Mar 2008  |   BioResearch